REGN
Regeneron Pharmaceuticals Inc
927.90$
+13.3%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Regeneron Pharmaceuticals Inc (REGN) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/30/2026 | Current report (8-K) | REGENERON PHARMACEUTICALS, INC. (REGN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 10/30/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 10/30/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 10/30/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 10/14/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 10/06/2026 | Current report (8-K) | REGENERON PHARMACEUTICALS, INC. (REGN): Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Other Events | View report ↗ |
| 09/30/2026 | Current report (8-K) | REGENERON PHARMACEUTICALS, INC. (REGN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report ↗ |
| 09/03/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/02/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/02/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/10/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/10/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/30/2026 | Current report (8-K) | REGENERON PHARMACEUTICALS, INC. (REGN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/06/2026 | Current report (8-K) | REGENERON PHARMACEUTICALS, INC. (REGN): Results of Operations and Financial Condition | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.